Platelet Rich Plasma Market Size, Share, and Trends 2024 to 2034

Platelet Rich Plasma Market Size and Forecast 2024 to 2034

The global platelet rich plasma market size accounted for USD 834.74 million in 2024 and is expected to be worth around USD 3,466.11 million by 2034, at a CAGR of 15.3% from 2024 to 2034.

Platelet Rich Plasma Market Key Takeaways

• North America led the global market with the highest market share of 44% in 2023.
• By Product, the Pure PRP segment has held the largest market share in 2023.
• By Application, the orthopedics segment captured the biggest revenue share in 2023.
• By Origin, the autologous platelet-rich plasma segment is estimated to hold the highest market share in 2023.

U.S. Platelet Rich Plasma Market Size and Growth 2024 to 2034

The U.S. platelet rich plasma market size was estimated at USD 223.42 million in 2023 and is predicted to be worth around USD 1,092.52 million by 2034, at a CAGR of 15.5% from 2024 to 2034.

Geographically, North America garnered major stake in the global platelet-rich plasma market as it is base of most significant players who are operating in the field of PRP market. North America and Europe are likely to lead the global market arena throughout the prediction period, mostly owed to the great occurrence of orthopedic disorders, upsurge in occurrence rates of rheumatology, intensification in the amount of sport wounds, and rush in acceptance of platelet-rich plasma therapy.

Asia Pacific is anticipated to record the rapid growth during upcoming years. Government bodies of emerging nations such as Mexico, India, and Brazil, are making enormous investments to create alertness concerning plasma therapy. PRP marketplace is expected to advance at a lucrative rate as it has the latent to support in delivering improved management of numerous orthopedic problems associated to wrist, elbow, shoulder, hip, back, knee, and ankle, which are on the upsurge in evolving regions.

Platelet Rich Plasma Market Growth Factors

Platelet rich plasma (PRP) therapy has gathered substantial attention over the last few decades, primarily owed to its latent capability in regenerative medicine such as maxillofacial and oral surgery, veterinary and sports medicine. Platelets as a key component of the PRP, comprise above 1100 diverse proteins, with plentiful post-translational alterations, ensuing in above 1500 protein-based bioactive aspects. These aspects embrace growth factors, immune system messengers, enzymes and their inhibitors and other factors which can contribute in wound healing and tissue repair.

Intensifying elderly population and mounting pervasiveness of orthopedic circumstances are certain other influences pushing the growth of platelet rich plasma marketplace. As per data published by National Center for Biotechnology Information, more than 1.4 million people are identified with fractures associated to osteoporosis each year. Furthermore, intensifying alertness related to platelet rich plasma therapy for dental treatment is projected to augment the market development.

Market Scope

Product Insights

Among different product segment analyzed in this research report, pure PRP conquered the overall market in 2023. Pure PRP reduces red neutrophils and blood cells. Neutrophils and red blood cells, white blood cell, have no therapeutic effect, and also encompass inflammatory components, which may upsurge pain post treatment. Nevertheless, leukocyte-rich fibrin is anticipated to progress at the fastest growth rate during the estimate period. Leukocyte-rich fibrin offers enhanced healing response and suggestively decreased retrieval time.

Application Insights

Different applications covered in the market are cosmetic surgery, orthopedic surgery, neurosurgery, general surgery and others. Among all, in 2023, orthopedics application segment led the global PRP market. Osteoarthritis is the most dominant kind of arthritis, and it affects around 31 million Americans each year. Due to increasing elderly populace, occurrence of doctor-diagnosed arthritis is projected to upsurge suggestively during prediction period.

Cosmetic surgery segment is projected to advance at rapid pace within assessment period on account of intensification in the applications of platelet-rich plasma products in hair transplant and other cosmetic applications. Platelet-rich plasma therapy is witnessing a momentous growth in its acceptance and reception for arthritis treatment as it impedes inflammation, cuts the rate of progression of osteoarthritis, motivates the formation of new cartilage, and upsurges the production of natural lubricating joint fluid. In this way, it eases painful joint friction, and also encompasses proteins that modify a patient's pain receptors and decreases pain sensation. Thus, the above-mentioned factors are anticipated to accelerate the growth of the arthritis segment.

Origin Insights

Depending on origin, global platelet-rich plasma market has been categorized into autologous, allogeneic, and homologous platelet-rich plasma. The autologous platelet-rich plasma segment is expected to govern the global platelet-rich plasma market throughout the estimate period on account of purging of cost for the fees to be paid to blood donors and clinical scrutiny of blood-borne diseases.

Platelet Rich Plasma Market Companies

• Zimmer Biomet
• Arthrex, Inc.
• Harvest Technologies Corporation
• Stryker Corporation
• DePuy Synthes, Inc.
• Cesca Therapeutics, Inc.
• AdiStem Ltd.
• Exactech Inc.
• ISTO Biologics
• Nuo Therapeutics

Segments Covered in the Report

By Product

• Leukocyte Rich PRP
• Pure PRP
• Leukocyte Rich Fibrin

By Origin

• Allogeneic PRP
• Autologous PRP
• Homologous PRP

By Application

• Cosmetic Surgery & Dermatology
• Orthopedic Surgery
• General Surgery
• Ophthalmic Surgery
• Neurosurgery
• Other

Regional Outlook

• North America
• Asia Pacific
• Europe
• Latin America
• The Middle East and Africa